A detailed history of Black Rock Inc. transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Black Rock Inc. holds 5,793,383 shares of COLL stock, worth $190 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,793,383
Previous 5,865,899 1.24%
Holding current value
$190 Million
Previous $228 Million 18.08%
% of portfolio
0.0%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$31.36 - $39.99 $2.27 Million - $2.9 Million
-72,516 Reduced 1.24%
5,793,383 $187 Million
Q1 2024

May 10, 2024

BUY
$31.23 - $40.91 $2.46 Million - $3.23 Million
78,906 Added 1.36%
5,865,899 $228 Million
Q4 2023

Feb 13, 2024

SELL
$21.16 - $30.8 $9.61 Million - $14 Million
-453,971 Reduced 7.27%
5,786,993 $178 Million
Q3 2023

Nov 13, 2023

BUY
$21.23 - $24.28 $3.45 Million - $3.95 Million
162,645 Added 2.68%
6,240,964 $139 Million
Q2 2023

Aug 11, 2023

BUY
$21.06 - $24.0 $5.61 Million - $6.39 Million
266,330 Added 4.58%
6,078,319 $131 Million
Q1 2023

May 12, 2023

BUY
$23.0 - $29.88 $1.83 Million - $2.38 Million
79,724 Added 1.39%
5,811,989 $139 Million
Q4 2022

Feb 13, 2023

SELL
$16.14 - $23.55 $175,361 - $255,870
-10,865 Reduced 0.19%
5,732,265 $133 Million
Q3 2022

Nov 14, 2022

BUY
$15.46 - $20.1 $1.42 Million - $1.85 Million
92,014 Added 1.63%
5,743,130 $92 Million
Q2 2022

Aug 12, 2022

SELL
$14.22 - $20.88 $941,207 - $1.38 Million
-66,189 Reduced 1.16%
5,651,116 $100 Million
Q1 2022

May 12, 2022

BUY
$17.2 - $22.5 $1.47 Million - $1.93 Million
85,645 Added 1.52%
5,717,305 $116 Million
Q4 2021

Feb 10, 2022

BUY
$17.5 - $21.35 $76,160 - $92,915
4,352 Added 0.08%
5,631,660 $105 Million
Q3 2021

Nov 09, 2021

SELL
$17.75 - $25.39 $697,912 - $998,309
-39,319 Reduced 0.69%
5,627,308 $111 Million
Q2 2021

Aug 11, 2021

BUY
$21.74 - $25.28 $123 Million - $143 Million
5,666,627 New
5,666,627 $134 Million

Others Institutions Holding COLL

About COLLEGIUM PHARMACEUTICAL, INC


  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.12B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.